{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:36:59Z","timestamp":1792654619728,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.gassur.2025.102207","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T23:26:59Z","timestamp":1758065219000},"page":"102207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gastric neuroendocrine tumors arising from chronic proton pump inhibitor use: characteristics and outcomes of a fourth subtype"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7541-8239","authenticated-orcid":false,"given":"Lena K.","family":"Egbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Kartik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Wasif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Poruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis E.","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gassur.2025.102207_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2025.102207_bib2","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejso.2018.01.082","article-title":"Incidence and survival trends for gastric neuroendocrine neoplasms: an analysis of 3523 patients in the SEER database","volume":"44","author":"Cao","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2025.102207_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/ijms21020662","article-title":"Proton pump inhibitor use, hypergastrinemia, and gastric carcinoids-what is the relationship?","volume":"21","author":"McCarthy","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.gassur.2025.102207_bib4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-F","article-title":"Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study","volume":"104","author":"Rindi","year":"1993","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gassur.2025.102207_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bpg.2005.05.002","article-title":"Endocrine tumours of the stomach","volume":"19","author":"Delle Fave","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.gassur.2025.102207_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas","volume":"39","author":"Kulke","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.gassur.2025.102207_bib7","unstructured":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) for neuroendocrine and adrenal tumors. version 1.2025. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2025 [accessed 2025 May 19].\u00a0Available from: \u3008https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf\u3009."},{"issue":"8","key":"10.1016\/j.gassur.2025.102207_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13306","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3","volume":"35","author":"Panzuto","year":"2023","journal-title":"J Neuroendocr"},{"issue":"3","key":"10.1016\/j.gassur.2025.102207_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0016-5085(99)70174-5","article-title":"ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis","volume":"116","author":"Rindi","year":"1999","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gassur.2025.102207_bib10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00000478-200608000-00003","article-title":"Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity","volume":"30","author":"Jiang","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.gassur.2025.102207_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jso.27876","article-title":"Classification of gastric neuroendocrine tumors and associations with survival","volume":"131","author":"Song","year":"2025","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2025.102207_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5858\/arpa.2020-0315-OA","article-title":"Enterochromaffin-like cell hyperplasia\u2013associated gastric neuroendocrine tumors may arise in the setting of proton pump inhibitor use: the need for a new clinicopathologic category","volume":"146","author":"Rais","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.gassur.2025.102207_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/his.14220","article-title":"Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis","volume":"77","author":"Trinh","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.gassur.2025.102207_bib14","first-page":"98","article-title":"Association of long-term PPI use with low-risk gastric neuroendocrine tumor","author":"Al-Toubah","year":"2023","journal-title":"Bioscientifica"},{"issue":"1","key":"10.1016\/j.gassur.2025.102207_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-201x.2000.00688.x","article-title":"Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation","volume":"169","author":"Bakke","year":"2000","journal-title":"Acta Physiol Scand"},{"issue":"7","key":"10.1016\/j.gassur.2025.102207_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/apt.12012","article-title":"Gastric carcinoids after long-term use of a proton pump inhibitor","volume":"36","author":"Jianu","year":"2012","journal-title":"Aliment Pharmacol\u00a0Ther"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25002665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25002665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:27:07Z","timestamp":1760218027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X25002665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1091255X25002665"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102207","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastric neuroendocrine tumors arising from chronic proton pump inhibitor use: characteristics and outcomes of a fourth subtype","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102207"}}